| A1c | Hemoglobin A1c |
| ACE | Angiotensin-Converting Enzyme |
| ACC | American College of Cardiology |
| AHA | American Heart Association |
| AI | Artificial Intelligence |
| ARB | Angiotensin Receptor Blocker |
| ASCVD | Atherosclerotic Cardiovascular Disease |
| BMI | Body Mass Index |
| CDC | Centers for Disease Control and Prevention |
| CDS | Clinical Decision Support |
| CKD | Chronic Kidney Disease |
| CKM | Cardiovascular-Kidney-Metabolic |
| CVD | Cardiovascular Disease |
| eGFR | Estimated Glomerular Filtration Rate |
| EMR | Electronic Medical Record |
| GDMT | Guideline-Directed Medical Therapy |
| GLP-1 RA | Glucagon-Like Peptide-1 Receptor Agonist |
| KDIGO | Kidney Disease: Improving Global Outcomes |
| LDL | Low-Density Lipoprotein |
| LDL-C | Low-Density Lipoprotein Cholesterol |
| MI | Myocardial Infarction |
| MRA | Mineralocorticoid Receptor Antagonist |
| PCP | Primary Care Provider |
| PCE | Pooled Cohort Equation |
| PREVENTTM | Predicting Risk of CVD EVENTs (risk equations) |
| SGLT2 | Sodium-Glucose Co-transporter -2 |
| uACR | Urine Albumin-to-Creatinine Ratio |